Tibet Yiming Xiya Medicine received a government grant of 19.32 million, expected to increase profits by 2025.

Recently, Tibetan Yimingxiya Pharmaceutical Technology Co., Ltd. received a government subsidy of 19,322,657.00 yuan, accounting for 42.07% of the net profit attributable to the shareholders of the listed company for the year 2024 as audited. This subsidy is related to revenue and is related to the company's daily operating activities, and will be included in the other income for the year 2025, with an expected increase in the total profit of the company for the year 2025 by 19,322,657.00 yuan. However, the above data has not been audited, and the final accounting treatment and the impact on the company's income and expenses are subject to the audit results of the annual audit firm. The company advises investors to pay attention to investment risks.